In the yeast Saccharomyces cerevisiae, glucose represses the transcription of numerous genes, including those required for ethanol and alternate sugar metabolism, the glyoxylate shunt, the tricarboxylic acid cycle, respiration, gluconeogenesis, and mitochondrial function. Several regulatory genes which, when mutated, either allow glucoseinsensitive transcription or inhibit derepression upon glucose removal have been identified (34) . The mechanisms by which glucose repression occurs, however, remain largely obscure. We have previously implicated the glucose-induced adenyl cyclase signalling system in the inhibition of alcohol dehydrogenase II (ADH II; ADH2 gene) expression (7, 13, 16) . This mechanism, though, would account for only a small portion of the total glucose repression of ADH2 (7, 14) . We show in the present study that glucose-dependent control of ADR1 protein synthesis contributes significantly to the overall glucose regulation of ADH2 expression.
The ADR1 regulatory protein is a transcriptional activator of the ADH2 gene (14, 33) and is required for the dramatic 500-fold increase in ADH II activity, which is initiated upon depletion or removal of glucose from the growth medium (8) . Activation of ADH2 transcription requires the binding of ADR1 protein to a 22-bp dyad upstream activation sequence in the noncoding region of the ADH2 gene (35 indicates that such binding occurs through two zinc fingers located in the N-terminal region of ADR1 (35) and that the ability of ADR1 to bind ADH2 appears to be carbon source independent (31) . In addition to its control of ADH2, ADR1 is required for transcription of genes involved in peroxisome function (28) and for undefined factors required for nonfermentative growth (2) .
Glucose regulation of ADR1 function appears to occur principally at the posttranscriptional level since ADR1 mRNA levels do not differ significantly between glucoseand ethanol-grown cells (4, 12, 17) . Dominant mutations in ADRI (designated ADRJC), which allow glucose-insensitive ADH2 transcription (14) , have been identified as point mutations causing single amino acid substitutions between amino acids 227 and 239 of ADR1 (7, 16, 17) . While it was originally postulated that these mutations affected the cyclic AMP-dependent protein kinase phosphorylation site at ser-230 of ADR1 (7, 17) , more recent evidence indicates that this protein kinase inhibits ADR1 function by a mechanism that is independent of effects on ser-230 (16) . How ADRiC mutations activate ADR1 under glucose growth conditions remains unclear. It is apparent, however, that additional mechanisms controlling ADR1 function must be operative, since ADRJc-containing strains remain partly subject to the effects of glucose repression (10, 14) .
We have reported previously that ADH2 expression under glucose growth conditions increased linearly in response to increased ADR1 dosage (12) . This observation raises the possibility that changes in the rate of ADR1 protein synthesis may play a role in the control of ADR1 activation of ADH2 transcription. We report here that the rate of ADR1 protein synthesis increased dramatically within the first 40 min of shifting cells from glucose to ethanol growth medium. 
MATERIALS AND METHODS
Yeast strains. All yeast strains used in this study are isogenic to strain 500-16, MA4Ta adhIl-lI adh3 ural his4 trpl, and have been described previously (2, 12 Total yeast RNA was extracted as previously described (15) . Northern (RNA) analysis was conducted according to the manufacturer's specifications as described in the New England Nuclear GeneScreen Instruction Manual. The ADR1 hybridization probe, a 3.4-kb HindlIl fragment from plasmid YRp7-ADR1-23A (17) , was radiolabeled by using a random priming kit (Boehringer-Mannheim). ADR1 RNA levels were quantitated by densitometric analysis with an EC610 densitometer and normalized to the amount of rRNA present when comparing samples grown under glucose and ethanol growth conditions (15, 18) . rRNA has been found to be a useful standard for comparing ADRI mRNA extracted from cells harvested from the different growth conditions (3, 12, 15, 17) . The wild-type strain used in this study, which lacks ADH I activity, grows at the same rate in medium containing glucose as in medium containing ethanol, obviating a carbon source variation in rRNA levels (23 Peptide synthesis and antibody production. ADR1 peptides comprising amino acid residues 2 to 21 and 208 to 231 were synthesized by the method of Merrifield as previously described (29) . Conjugation of peptides to bovine serum albumin (BSA) and production of antibodies have been described previously (24, 25, 32) . Preimmune and immune sera were used without further purification. Anti-ADR1-208-231 peptide antibody immunoprecipitation of ADR1 polypeptide was found to be unaffected by phosphorylation of Ser-230 or mutation of the Arg-228 to lysine (ADR1-Sc allele) or Ser-230 to leucine (ADR1-7c allele) (data not shown).
Alkaline phosphatase treatment of ADR1. Treatment with alkaline phosphatase of immunoprecipitated radiolabeled ADR1 was accomplished by the method essentially as described by Barber and Verma (1). Radiolabeled ADR1 was liberated from the washed protein A-agarose immunoprecipitates by incubation for 2 min in a boiling-water bath following the addition of 100 RI of 50 mM Tris (pH 8.0) containing 2 mM PMSF, 5 mM dithiothreitol, and 0.3% (wt/vol) SDS. Following a brief spin (5 to 7 s) in the microfuge, the supematant containing the labelled ADR1 was transferred to fresh microfuge tubes and adjusted to contain 1% (vol/vol) Nonidet P-40, 1% (wt/vol) sodium deoxycholate (Sigma), and 150 mM NaCl. Neutralized ADR1 extracts were treated with 25 U of unweened-calf alkaline phosphatase (Sigma) at 37°C. Reactions were terminated by the addition of SDS sample buffer and incubation for 3 min in a boiling-water bath. The resulting samples were analyzed by using the SDS-PAGE and fluorography system described above. RESULTS ADR1 protein identification. The ADR1 protein was immunoprecipitated from SDS-denatured extracts of yeast cells labelled in vivo with 35S-amino acids. ADR1, immunoprecipitated with antibodies directed against a synthetic peptide corresponding to amino acid residues 208 to 231 of the ADR1 protein, migrated on SDS-polyacrylamide gels as a single species corresponding to a polypeptide of ca. 152 kDa ( polyacrylamide gel. Cultures of strain 500-16 (adrl-I) (lanes 4 and 5) and strain 411-1 (lane 6) were radiolabeled as described for lanes 1 to 3 except 310 ,uCi of 35S-amino acids per ml was used. To enhance detection of immunoprecipitated species, precleared extracts were first immunoprecipitated with anti-ADR1-208-231 antibody and then reimmunoprecipitated as described for lanes 2 and 3, respectively. Control experiments indicated that reimmunoprecipitation did not impair ADR1 detection. This figure is a composite of two different autoradiograms depicting the results of two different immunoprecipitation experiments (lanes 1 to 3 and lanes 4 to 6) and, as a result, shows variation in the patterns and intensities of nonspecific background bands.
obtained these results by using antisera raised against a peptide corresponding to amino acid residues 208 to 231 of ADR1 ( Fig. 1 to 4 ) or a second synthetic peptide corresponding to residues 2 to 21 of the ADR1 protein (see Fig. 3 to 5 and 7 to 10). Taken together, our results provide conclusive evidence that the identity of the polypeptide migrating at 152 kDa in lane 2 of Fig. 1 10 , lanes 9 and 10 compared with lanes 5 and 6) (data not shown).
Alkaline phosphatase treatment of ADR1 immunoprecipitated from cells pulse-labelled for 2 h with 35S-amino acids caused the size of the ADR1 signal to be dramatically reduced and to resemble the thin band produced at 152 kDa by ADR1 from cells pulse-labelled for 15 min (Fig. 2, Fig. 3 for lanes 7 to 14. Lanes: ADR1-5c, strain 6-60 (one copy ofADRI-55); 8-ADR1-5c, strain 6-2 (eight copies ofADRI-55); ADR1-7c, strain 7c-b (one copy of ADRI-7c).
synthesized ADR1 and indicate that ADR1 is multiply phosphorylated in vivo under both glucose and ethanol growth conditions during or soon after its synthesis (within 45 min).
The rate of ADR1 protein synthesis is reduced in glucosegrown cells. We observed the amount of ADR1 immunoprecipitated from extracts of ethanol-grown cells to be consistently and significantly greater than the amount of ADR1 immunoprecipitated from extracts of cells grown on glucose, suggesting that ADR1 activity might be regulated through a carbon source-linked control of ADR1 protein synthesis. Figure 3 illustrates the results of an ADR1 immunoprecipitation experiment using SDS-denatured extracts of yeast strain 411-40 (containing a single copy of ADR1) pulselabelled for 15 min with 35S-amino acids under glucose (lane 2) and ethanol (lane 5) growth conditions. As shown in the Fig. 3 , we were able to detect ADR1 under ethanol growth conditions but not under glucose growth conditions. We obtained similar results by Western analysis of whole-cell (strain 411-40) extracts (Fig. 3, lanes 15 and 16, (Fig. 5, lane 3) which was peptide blockable (Fig. 5, lane 4 (12) . Although cells from strain 411-12 produce only one-fourth of the amount of ADH II activity produced by the ADR1-5C single-gene-copy-containing strain (above), immunoprecipitates of glucose-grown 411-12 cells routinely produce a clearly visible ADR1 signal (Fig. 3, lane 16) . These results indicate that the ADR1C mutations cause enhanced ADR1 activity by a mechanism independent of ADR1 protein synthesis control.
Differences in ADRI mRNA abundance contribute slightly to the regulation of the rate of ADR1 protein synthesis. We next sought to identify the step, or steps, leading to the production of the ADR1 protein which are responsible for the observed increase in the rate of ADR1 protein synthesis. To distinguish between ADRI mRNA availability and other translational control mechanisms, we compared the levels of ADRI mRNA in glucose-and ethanol-grown cells. Previous investigations of strain 411-40 (single ADRI gene copy) and strains isogenic to 411-40 carrying multiple copies of the ADRI gene indicated the level of ADRI mRNA in glucosegrown cells to be comparable to or slightly less than that found in ethanol-grown cells (3, 12) . Although these strains are identical or comparable to the ones used in the present investigation, to ensure consistency between all phases of our analysis we measured ADRI mRNA levels by using the strains and growth conditions employed throughout our current investigation of the ADR1 protein abundance effect. Figure 6 illustrates the results obtained with a Northern blot analysis of ADR1 mRNA for strains 411-40 (1 ADRI gene copy) and 411-12 (16 ADR1 gene copies) grown on glucose (lanes G) and on ethanol (lanes Et). As shown, for each of the strains, the levels ofADR1 mRNA were found to be only slightly elevated in the ethanol-grown cells. Densitometric analysis indicates that ADRI mRNA, when normalized to rRNA, is twice as abundant under ethanol growth conditions as under glucose growth conditions. These results are essentially the same as those previously obtained by us (3, 12, 17) and others (4). It, therefore, appears that control mechanisms other than those controlling ADRI mRNA abundance must be responsible for the greater part of regulating the rate of ADR1 translation. unlabelled methionine showed identical levels of 35S label incorporated into proteins, indicating that the chase with nonradioactive methionine efficiently blocked all further incorporation of 35S-amino acids into total yeast proteins (Fig. 7b) . Minimal ADR1 protein degradation was observed during the first 2 to 3 h of the chase under glucose growth conditions (Fig. 7a) . (The apparent decreased abundance of ADR1 at time zero in Fig. 7a was due to the antigenic ADR1 peptide being added during the immunoprecipitation; other experiments showed that ADR1 abundance did not significantly change between 0 and 1 h after the chase.) The data presented in Fig. 7 indicate a half-life of 3 to 4 h for ADR1 under glucose growth conditions. Significant differences in the rates of ADR1 protein synthesis were observed, however, in cell extracts pulse-labelled for only 15 min. An accelerated rate of ADR1 protein degradation, therefore, cannot account for the relatively low level of ADR1 protein present under glucose growth conditions. Indeed, the halflife of the ADR1 protein was actually found to be slightly shorter (about 2-to 3-h half-life) (Fig. 8) ( 16 copies of ADRI) were radiolabeled to steady-state levels under glucose growth conditions, as described in Materials and Methods, and chased with unlabeled methionine. At the times indicated above the lanes, 2-ml portions were removed and extracts were prepared. (a) Precleared extracts normalized on the basis of TCA-precipitable counts (observed to be nearly equivalent volumes) immunoprecipitated with anti-ADR1-2-21 peptide antibody. The resultant immunoprecipitates were separated on a 10% polyacrylamide gel. (b) Equal volumes of total precleared extracts (essentially equivalent to equal amounts of precleared extracts based on TCA-precipitable counts). The immunoprecipitated ADR1 polypeptide is indicated by the arrow. Lane B2 contains precleared extracts from the 2-h time point treated with excess antigenic peptide and antibody. The rate of ADR1 protein turnover was determined after first calculating the ratio of the amount of radioactivity in the ADR1 protein immunoprecipitated band to the total TCA-precipitable counts for each time point.
within 1 h of depletion of glucose from the medium (14) . We, therefore, examined the rate of ADR1 protein synthesis during the time period immediately following removal of glucose from the medium to determine whether the increased ADR1 protein translation rate is correlated with the time at which ADR1 activation is presumed to occur. protein turnover under ethanol growth conditions. Conditions for determining ADR1 protein turnover were the same as those described in the legend to Fig. 7 , except growth of cells occurred in ethanol-containing medium. At the times indicated above the lanes, 2-ml portions were removed and extracts were prepared. (a) Equal volumes of precleared extracts were immunoprecipitated with anti-ADR1-2-21 peptide antisera, and the resultant immunoprecipitates were separated on 10% polyacrylamide gel; (b) equal volumes of precleared extracts (in this case not equivalent to equal amounts of TCA-precipitable counts) were subjected to SDS-PAGE. Lane B contains precleared extracts from the zero time point treated with antibody and excess antigenic peptide. within 40 to 60 min after shifting cells from glucose to ethanol growth conditions. At time points beyond the first 40 to 60 min (i.e., 220 min, 340 min, and 24 h) the rate of ADR1 synthesis remained relatively constant (Fig. 9) . Similar results were obtained for a strain (6-2) containing eight integrated copies of the ADR1-5c gene (data not shown). These results provide strong evidence that the glucose regulation of ADH2 expression by the control of ADR1 protein synthesis is a physiologically significant control mechanism since ADH2 expression is known to be directly responsive to the dosage of ADRI (12) .
The 510-nt 5' untranslated region of ADRI mRNA is not involved in ADR1 translational control. We investigated the potential role of the 510-nucleotide (nt) 5' untranslated region of ADRI mRNA in the control of ADR1 translation. While this region in ADRJ lacks short open reading frames found to be important in controlling translation of the yeast GCN4 mRNA (26) , we considered the possibility that other features contained within the region might mediate carbon source-dependent translation. To investigate this possibility, we replaced the 510-nt untranslated region ofADRI, includ- ing the upstream promoter sequences, with a truncated promoter derived from the glyceraldehyde 3-phosphate dehydrogenase (GAP) gene. The truncated GAP promoter was used because it is a low-expression promoter that would be expected to produce ADRI mRNA at levels equivalent to or only slightly higher than those normally expressed by the cell and because its efficiency is not regulated by the carbon source (27a).
Northern analysis indicated the level of G-ADRI mRNA in a yeast strain containing a single integrated dose of G-ADR1 to be approximately 15-fold higher than that in the isogenic strain carrying a singleADRJ gene copy (Fig. 6 , first two lanes compared with the third and fourth lanes). Thus, G-ADRJ produced ADRI mRNA in amounts which would be expected for a strain carrying about 15 copies of ADRI (12) . We determined ADH II enzyme activity in the G-ADR1-carrying strain for glucose and ethanol growth conditions to be 50 and 5,000 mU/mg, respectively. These values are consistent with those expected for a strain carrying 10 to 12 copies ofADRI (12) and are in good agreement with the elevated levels of G-ADRI mRNA production illustrated in Fig. 6 . The amount of G-ADR1 mRNA in ethanol-grown cells was determined to be twice that found under glucose growth conditions. In contrast, we determined the amount of ADR1 protein immunoprecipitated from 35S-amino acid extracts from the G-ADRI-carrying strain to be 10-to 15-fold greater under ethanol growth conditions than under glucose growth conditions (Fig. 3 , compare lanes 12 and 13), consistent with our above analysis of strains containing one or more copies of the complete ADRI gene. These surprising results indicate that the ADR1 translation rate differences under the glucose and ethanol growth conditions are retained when the 510-nt 5' untranslated region of ADRI mRNA is replaced with a different sequence and that this region is, therefore, not involved in the glucose regulation of ADR1 translation.
ADR1 coding sequences corresponding to amino acid residues 262 through 642 are involved in ADR1 translational control. Having determined that the 5' untranslated region of ADRI mRNA does not control the ADR1 translation rate, (2) . (The numbers 642 and 262 correspond to the numbers of N-terminal ADR1 amino acids in the truncated ADR1 protein products expressed in each strain.) The ADR1-642 protein from strain B19 gave a boldly visible signal following growth on ethanol-containing medium but was not detected in glucose-grown cells (Fig. 10, lanes 3 and 2, respectively) . These results are similar to those observed for the full-length ADR1 protein and would be expected if the translational control mechanism does not become disrupted as a result of removal of over half of the ADR1 coding sequence (681 C-terminal residues). Similar results were obtained with a yeast strain containing only nine copies of ADR1-642 (data not shown). Also, the amounts of ADRI-642 mRNA, when normalized to rRNA levels, were found to be only slightly elevated in ethanol-grown cells compared with glucosegrown cells, data consistent with our observations for strains containing the full-length ADRI gene.
The ADR1-262 protein, in contrast to ADR1-642 and ADR1-1323, was observed to yield boldly visible signals under both glucose and ethanol growth conditions. Densitometric analysis indicated ADR1-262 protein, though present in two forms, to be equally abundant in glucose-and ethanolgrown cells (Fig. 10, lanes 5 and 7) . We presume the two forms of ADR1-262, which migrate in the 40-kDa region of the SDS-polyacrylamide gel, to be due to the occurrence of multiple phosphorylated species (both species are phosphoproteins; Fig. 10, lanes 9 and 10) or possibly to proteolysis. Antibodies directed against ADR1 peptides corresponding to regions 208 to 231 and 2 to 21 immunoprecipitated both forms with equal efficiencies (data not shown), indicating that the majority of the 262 amino acids were intact. Although the observed abundance differences of the individual forms of ADR1-262 between glucose and ethanol growth conditions were not reproducible, the total amount of ADR1 protein (both forms together) always remained equivalent under the two growth conditions. The ADR1-262 mRNA levels were found to be similar under ethanol and glucose growth conditions (data not shown), results which are consistent with the ADR1 protein synthetic rates determined for ADR1-262 and the ADRI mRNA patterns observed for all of the strains investigated in this study. The translational control of ADR1 appears mediated, therefore, by sequences localized within the coding region of the transcript corresponding to amino acid residues 262 through 642 of the ADR1 protein.
DISCUSSION
The results of our investigation demonstrate that the rate of protein synthesis for the transcriptional activator ADR1 is 10-to 16-fold greater under ethanol growth conditions than under glucose growth conditions. This derepression in ADR1 protein translation was found to occur within 40 to 60 min of depleting cells of glucose, the same time frame defined previously for the commencement of ADR1-dependent ADH2 transcription (14) . Our results indicate that glucose represses ADH2 expression by reducing the rate of ADR1 protein synthesis, a conclusion supported by our previous observation that linear increases in ADR1 dosage result in corresponding linear increases in the amount of ADR1 mRNA and in ADH2 expression under glucose growth conditions (12) . Strains containing ADRlC alleles display reduced levels of ADR1 protein synthesis under repressed conditions in a manner similar to that observed for strains expressing the wild-type ADR1 allele. We, therefore, conclude that the mechanism by which ADRIC alleles cause increased ADH2 transcription must be distinct from that responsible for effecting changes in the rate of ADR1 protein translation.
Our previous studies indicate that yeast strains expressing a single copy of the ADR1C allele show an eightfold increase in ADH2 transcription within 1 h of shifting cells from glucose to ethanol growth conditions (14) . Our current data suggest that this increase is a direct result of increased ADR1 protein synthesis signalled by glucose depletion. Interestingly, strains carrying eight copies of anADRlC allele display glucose-repressed ADH II levels that are nearly equivalent to the level of ADH II found under ethanol growth conditions in an isogenic strain containing a single wild-type ADRI allele (12) . We interpret these results to suggest that the overall derepression ofADH2 results from the combined effects of increased ADR1 protein translation rates and some other activation of the already synthesized ADR1 protein (equivalent to an ADRlC allele). The posttranslational activation may, as previously suggested, be triggered by a dephosphorylation event (7, 16 The molecular mechanism by which glucose reduces the rate of ADR1 translation, other than the small effect of ADR1 mRNA levels, remains unclear. None of the genes known to affect ADH2 expression, including CCR1, ADR6, CCR4, CRE1, and CRE2 (9, 11, 30) appear likely to be involved in controlling ADR1 mRNA translation. Previous searches for trans-acting genes that affect ADH2 expression under glucose growth conditions have identified onlyADRlc mutations or mutations in the CRE genes, the latter of which act independently of ADR1 in controlling ADH2 expression (11) . Interestingly, the sequence in ADR1 between nt 840 and 869 (corresponding to amino acids 281 and 290) predicts a perfect 13-nt stem and 4-nt loop structure. It remains possible that such a stem-loop might operate to impede translation directly or to serve as a binding site for a protein that, in turn, functions to regulate ADR1 translation rate. Deletion of this region, however, appears to have no effect on ADR1-dependent ADH2 expression (unpublished observations The possibility therefore exists that glucose-induced increases in ADR1 plasmid dosage (in order to maintain the high ADH II activity required for fermentative growth) (12) and ethanol-induced reductions inADRJ plasmid dosages (in order to reduce ADR1-induced petite formation) (6) might have influenced the results. Because in this other study (31) neither the relative levels of ADRI mRNA nor the rates of ADR1 protein degradation or synthesis were analyzed for the one strain not containing plasmid-borne copies of ADR1, it is not possible to fully interpret the significance of these results with respect to ours. The regulation of ADR1 protein synthesis could be strain dependent since it has been observed that a couple of yeast strains, in contrast to the vast majority of strains analyzed (3, 4, 12, 17) (Fig. 6) , display much reduced ADRI mRNA levels under glucose growth conditions (4). We have analyzed one of these strains (4) Fig. 6a and b, appear to be significantly more stable than ADR1. ADH I and ADH II also have relatively long half-lifes in comparison to ADR1, on the order of at least 20 hours (10a, 19) . We have also observed that the transcriptional activator CCR4 displays a half-life of 7 to 9 h (unpublished observations). The relatively short half-life of ADR1 protein suggests a mechanism for controlling cellular levels of ADR1 and for removing altered or damaged forms of ADR1 which may potentially decrease the efficiency of ADH2 regulation. It is unclear whether the relatively rapid degradation observed for ADR1 is generally true for other transcriptional factors or whether such a mechanism contributes to the low cellular levels observed for such proteins. Such a mechanism might minimize the deleterious effects known to result from their overproduction in yeast cells (6, 21) .
We also have demonstrated that ADR1 is a phosphoprotein. Phosphorylation of ADR1 occurred at multiple sites to generate multiple forms of the ADR1 protein that were distinguishable on the basis of their SDS-PAGE migration patterns and in their sensitivity to in vitro dephosphorylation by alkaline phosphatase. Phosphorylation of ADR1 was found to occur in cells pulse-labelled for only 15 min (data not shown), indicating that it occurred either during ADR1 translation or soon after translation was completed. The pattern of ADR1 phosphorylation also appeared to be the same in ethanol-and glucose-grown cells on the basis of SDS-PAGE analysis.
